Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Lu AF35700 in Renal Impairment
NCT03241147Phase 1Terminated
- Sponsor
- Lundbeck
- Start
- Jul 2017
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of lu af35700 in schizophrenia (4 arms), sponsored by Lundbeck. Primary endpoints: Area Under the Curve from time zero to infinity and Maximum Plasma Concentration. Started Jul 2017; status: terminated.
02
Drugs
lu af35700
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03241147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03241147.